Stay updated on Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.

Latest updates to the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedUpdates the page to v3.2.0 with a government-funding status notice for the NIH Clinical Center and links for current operating status; removes the previous v3.1.0 revision.SummaryDifference4%
- Check23 days agoChange DetectedUpgrade from v3.0.2 to v3.1.0, updating the page revision/version.SummaryDifference0.1%
- Check30 days agoChange DetectedRemoved three core topics (Electromagnetic Radiation, Magnetic Phenomena, and Electromagnetic Phenomena) from the page; this substantially narrows or changes the page’s subject matter without replacing them with new content.SummaryDifference0.3%
- Check38 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1. The Back to Top element was removed.SummaryDifference0.2%
- Check45 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check52 days agoChange DetectedThe web page has added significant content related to radiation therapy, including new topics and a facility name, while removing several specific location details and references to certain medical resources.SummaryDifference3%
Stay in the know with updates to Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.